Retinoic Acid (RA) signaling is mediated by the Retinoic Acid Receptor (RAR), belonging to the Nuclear Hormone Receptor superfamily. In addition to its classical transcriptional actions, RAR also mediates rapid transcription-independent actions (also called non-genomic), consisting in the activation of signal transduction pathways, as the phosphatidyl-inositol-3-kinase (PI3K) or the ERK MAP-kinase signaling pathways. RA-induced rapid actions play roles in different physiological contexts. As an effort towards understanding the functions of those rapid actions on signaling elicited by RA, we have identified nuclear proteins whose phosphorylation state is rapidly modified by RA treatment in neuroblastoma cells, using a proteomic approach. Our results show that RA treatment led to changes in the phosphorylation patterns in two families of proteins: (i) those related to chromatin dynamics in relation to transcriptional activation, and (ii) those related to mRNA processing and in particular mRNA splicing. We show that treatment of neuroblastoma cells with RA leads to alteration of the regulation of pre-mRNA splicing and mRNA translation, via the activation of signaling pathways. Thus, our results underscore novel functions for the non-genomic signaling elicited by RAR in the regulation of mRNA processing, as part of a cellular response orchestrated by the nuclear receptor RAR. The results shown here contribute to the idea that transcriptional and transcription-independent actions elicited by nuclear hormone receptors are integrated and converge at multiple levels in the regulation of gene expression. 
Short RA treatments lead to modifications in the phosphorylation patterns of nuclear proteins
Short RA treatments induce the activation of the PI3K signalling pathway and its downstream components mTOR and p70S6 Kinase (Fig. 1A) . Western blot with an antibody against phospho-serine/threonine residues within Akt kinase phosphorylation consensus site (RXRXXS/T), revealed that RA treatment increased rapidly the phosphorylation of several Akt substrate proteins, detectable in whole cell extracts (Fig. 1B) , as well as in nuclear extract (Fig. 1C) . 2-DE western blots demonstrate that RA treatment leads to an increase in the number and intensity of the spots corresponding to phosphorylated Akt substrates in nuclear extracts from neuroblastoma cells (Fig. 1D) . 
Conclusions

RA regulates translation through the activation of signaling pathways
By using a translation reporter gene containing a binding site for SF2/ASF (Fig.  6A) we show RA-induced increase in translation, that was sensitive to inhibitors of both PI3K and ERK-MAP kinase pathways (Fig.6B) . RA increases the phosphorylation of 4E-BP1, an inhibitor of cap-binding eIF4E, through the activation of PI3K (Fig. 6C) . However additional mechanisms must exist to explain the effects of MEK inhibitor U0126, that does not interferes the activation of PI3K pathway (Fig. 6D) .
Using a splicing reporter minigene based on E1A (Fig. 5A) we could show that RA treatment alters the pattern of alternative splicing. This regulation is sensitive to PI3K inhibitors, but not to MAP kinase inhibitors. (Figs. 5B and C) . The interaction betweenthe SR protein SF2/ASF and the U1-70K spliceosome protein is increased by RA treatment, as shown in immunoprecipitation experiments (Fig. 5D) 5. RA influences the regulation of alternative splicing via activation of signaling pathways 
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